Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | SVP, Chief Marketing Officer | May 22, 2026 | May 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date May 22, 2026 · Filed May 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 41,480 |
Reported balance
After 2026-05-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-22 · Sale · Disposed 11,876 · Balance 41,480 F1: The shares were sold in multiple transactions at prices ranging from $54.315 to $55.08 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2: Shares held following the reported transaction includes 41,480 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold in multiple transactions at prices ranging from $54.315 to $55.08 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2: Shares held following the reported transaction includes 41,480 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2021 Filed Feb 23, 2021 01:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 2,100 | $68.40 | $143,640.00 |
DisclosureSEC source: 0001209191-21-013012 · doc4.xml · nonDerivative · entry 5 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 32,956 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 01:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,813 | $94.11 | $735,250.96 |
DisclosureSEC source: 0001209191-21-013012 · doc4.xml · nonDerivative · entry 4 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,262 F2 · price: The shares were sold in multiple transactions at prices ranging from $94.02 to $94.385, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 32,956 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 01:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 7,813 | $62.43 | $487,765.59 |
DisclosureSEC source: 0001209191-21-013012 · doc4.xml · nonDerivative · entry 3 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 32,956 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 01:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,250 | $94.00 | $211,500.00 |
DisclosureSEC source: 0001209191-21-013012 · doc4.xml · nonDerivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,262 F1 · balance_after: Shares held following the reported transactions include 32,956 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 01:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 2,250 | $64.60 | $145,350.00 |
DisclosureSEC source: 0001209191-21-013012 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 32,956 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 22:50 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,116 | $91.03 | $101,589.48 |
DisclosureSEC source: 0001209191-20-064694 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,262 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 32,956 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 00:26 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,153 | $92.08 | $106,168.24 |
DisclosureSEC source: 0001209191-20-064234 · doc4.xml · nonDerivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,378 F3 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F4 · balance_after: Shares held following the reported transactions include 35,206 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:26 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 27,253 | $0.00 Strike: $92.08 | $0.00 |
DisclosureSEC source: 0001209191-20-064234 · doc4.xml · derivative · entry 4 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,253 Underlying: Class A Common Stock · 27,253 shares Expires 2030-12-15 F6 · derivative.exercise_date: This option was granted for a total of 27,253 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2020, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:26 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 6,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-064234 · doc4.xml · derivative · entry 3 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,365 Underlying: Class A Common Stock · 6,365 shares Expires not disclosed F5 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F5 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F5 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:26 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 12,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-064234 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,531 F1 · acquired: Award represents a total of 12,731 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2020. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 37,531 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 21:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,191 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001209191-20-060512 · doc4.xml · derivative · entry 3 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Class A Common Stock · 5,191 shares Expires 2028-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 36,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 21:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 5,191 | $89.69 | $465,567.29 |
DisclosureSEC source: 0001209191-20-060512 · doc4.xml · nonDerivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,800 F2 · price: The shares were sold in multiple transactions at prices ranging from $89.63 to $89.76, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 24,800 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 21:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 5,191 | $64.60 | $335,338.60 |
DisclosureSEC source: 0001209191-20-060512 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 24,800 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:28 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,862 | $89.87 | $257,196.78 |
DisclosureSEC source: 0001209191-20-059654 · doc4.xml · nonDerivative · entry 5 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,800 F4 · price: The shares were sold in multiple transactions at prices ranging from $89.85 to $89.95, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 24,800 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:28 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 26,041 | $89.35 | $2,326,812.83 |
DisclosureSEC source: 0001209191-20-059654 · doc4.xml · nonDerivative · entry 4 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,662 F3 · price: The shares were sold in multiple transactions at prices ranging from $89.006 to $89.77, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 24,800 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:28 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 26,041 | $62.43 | $1,625,739.63 |
DisclosureSEC source: 0001209191-20-059654 · doc4.xml · nonDerivative · entry 3 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 24,800 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:28 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,309 | $89.80 | $207,351.20 |
DisclosureSEC source: 0001209191-20-059654 · doc4.xml · nonDerivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,662 F2 · price: The shares were sold in multiple transactions at prices ranging from $89.77 to $89.88, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 24,800 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:28 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 2,309 | $64.60 | $149,161.40 |
DisclosureSEC source: 0001209191-20-059654 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 24,800 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| July 16, 2020 Filed Jul 17, 2020 00:04 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,513 | $66.00 | $99,858.00 |
DisclosureSEC source: 0001209191-20-042701 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,662 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 24,800 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:29 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 46,875 | $0.00 Strike: $62.43 | $0.00 |
DisclosureSEC source: 0001209191-20-010529 · doc4.xml · derivative · entry 7 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,125 Underlying: Class A Common Stock · 46,875 shares Expires 2028-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:29 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,750 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001209191-20-010529 · doc4.xml · derivative · entry 6 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Class A Common Stock · 9,750 shares Expires 2028-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 36,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:29 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 4,333 | $72.20 | $312,842.60 |
DisclosureSEC source: 0001209191-20-010529 · doc4.xml · nonDerivative · entry 5 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,175 F1 · balance_after: Shares held following the reported transactions include 29,175 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:29 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 46,875 | $72.28 | $3,387,900.00 |
DisclosureSEC source: 0001209191-20-010529 · doc4.xml · nonDerivative · entry 4 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,508 F3 · price: The shares were sold in multiple transactions at prices ranging from $72.185 to $72.32, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 29,175 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:29 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 46,875 | $62.43 | $2,926,406.25 |
DisclosureSEC source: 0001209191-20-010529 · doc4.xml · nonDerivative · entry 3 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,383 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 29,175 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:29 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 9,750 | $72.32 | $705,161.93 |
DisclosureSEC source: 0001209191-20-010529 · doc4.xml · nonDerivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,508 F2 · price: The shares were sold in multiple transactions at prices ranging from $72.32 to $72.40, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 29,175 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:29 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 9,750 | $64.60 | $629,850.00 |
DisclosureSEC source: 0001209191-20-010529 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 29,175 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 14, 2020 Filed Nov 20, 2020 21:28 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 26,041 | $0.00 Strike: $62.43 | $0.00 |
DisclosureSEC source: 0001209191-20-059654 · doc4.xml · derivative · entry 7 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,084 Underlying: Class A Common Stock · 26,041 shares Expires 2028-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 14, 2020 Filed Nov 20, 2020 21:28 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,309 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001209191-20-059654 · doc4.xml · derivative · entry 6 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,941 Underlying: Class A Common Stock · 2,309 shares Expires 2028-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 36,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 02:54 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 779 | $68.40 | $53,283.60 |
DisclosureSEC source: 0001209191-19-061241 · doc4.xml · nonDerivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,508 F3 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F4 · balance_after: Shares held following the reported transactions include 29,175 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2019 Filed Dec 19, 2019 02:54 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 42,275 | $0.00 Strike: $68.40 | $0.00 |
DisclosureSEC source: 0001209191-19-061241 · doc4.xml · derivative · entry 4 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,275 Underlying: Class A Common Stock · 42,275 shares Expires 2029-12-16 F6 · derivative.exercise_date: This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 16, 2019 Filed Dec 19, 2019 02:54 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 4,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061241 · doc4.xml · derivative · entry 3 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,650 Underlying: Class A Common Stock · 4,650 shares Expires not disclosed F5 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F5 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F5 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 16, 2019 Filed Dec 19, 2019 02:54 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 9,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061241 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,287 F1 · acquired: Award represents a total of 9,300 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 16, 2019. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 31,425 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 21:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,513 | $65.28 | $98,768.64 |
DisclosureSEC source: 0001209191-19-042664 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,987 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 22,125 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 17, 2018 Filed Dec 20, 2018 01:02 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001209191-18-063594 · doc4.xml · derivative · entry 3 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Class A Common Stock · 36,000 shares Expires 2028-12-17 F4 · derivative.exercise_date: This option was granted for a total of 36,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 17, 2018 Filed Dec 20, 2018 01:02 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Stock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001209191-18-063594 · doc4.xml · derivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Class A Common Stock · 18,000 shares Expires 2025-12-17 F3 · derivative.exercise_date: The vesting of this performance-based stock option ("PSO") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 17, 2018 and ending December 17, 2021. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 125% of the target award amount based on total shareholder return at the end of the three-year performance period. The actual PSO award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 17, 2018 Filed Dec 20, 2018 01:02 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-063594 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,500 F1 · acquired: Award represents a total of 9,000 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 17, 2018. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 26,500 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 20:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $62.43 | $0.00 |
DisclosureSEC source: 0001209191-18-043030 · doc4.xml · derivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Class A Common Stock · 125,000 shares Expires 2028-07-16 F3 · derivative.exercise_date: This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vest on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 20:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-043030 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 F1 · acquired: Award represents a total of 17,500 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of July 16, 2018. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 17,500 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.